Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances

SM Hosseini, B Borys, S Karimi-Abdolrezaee - Brain, 2024 - academic.oup.com
Traumatic spinal cord injury (SCI) is a leading cause of lifelong disabilities. Permanent
sensory, motor and autonomic impairments after SCI are substantially attributed to …

[HTML][HTML] Beneath the radar: immune-evasive cell sources for stroke therapy

BA Buil, NH Rentsch, RZ Weber, C Rickenbach… - Trends in Molecular …, 2024 - cell.com
Stem cell therapy is an emerging treatment paradigm for stroke patients with remaining
neurological deficits. While allogeneic cell transplants overcome the manufacturing …

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”

DS Karpov, AO Sosnovtseva, SV Pylina… - International Journal of …, 2023 - mdpi.com
Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by the destruction of
insulin-producing β-cells in the pancreas by cytotoxic T-cells. To date, there are no drugs …

Human iPSC–Derived Endothelial Cells Exhibit Reduced Immunogenicity in Comparison With Human Primary Endothelial Cells

H Jia, M Moore, M Wadhwa, C Burns - Stem Cells International, 2024 - Wiley Online Library
Human induced pluripotent stem cell (iPSC)–derived endothelial cells (ECs) have emerged
as a promising source of autologous cells with great potential to produce novel cell therapy …

Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes

T Eschenhagen, F Weinberger - Nature Cardiovascular Research, 2024 - nature.com
Here we aim at providing a concise but comprehensive overview of the perspectives and
challenges of heart repair with pluripotent stem cell-derived cardiomyocytes. This Review …

[HTML][HTML] Ultrastructural Abnormalities in Induced Pluripotent Stem Cell-Derived Neural Stem Cells and Neurons of Two Cohen Syndrome Patients

TA Shnaider, AA Khabarova, KN Morozova… - Cells, 2023 - mdpi.com
Cohen syndrome is an autosomal recessive disorder caused by VPS13B (COH1) gene
mutations. This syndrome is significantly underdiagnosed and is characterized by …

Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives

ME Bogomiakova, AN Bogomazova… - Biochemistry (Moscow …, 2024 - Springer
Induced pluripotent stem cells (iPSCs), capable of differentiating into any cell type, are a
promising tool for solving the problem of donor organ shortage. In addition, reprogramming …

Immunogenicity of autologous and allogeneic human primary cholangiocyte organoids

S Petrus-Reurer, O Tysoe, W Lei, M Mairesse, T Tan… - bioRxiv, 2024 - biorxiv.org
Primary human cells cultured in 3D organoid format have great promise as potential
regenerative cellular therapies, but their immunogenicity has not yet been fully …

[PDF][PDF] In vitro оценка иммуногенности хондроцитов, полученных из индуцированных плюрипотентных стволовых клеток с нокаутом B2M

АА Баринова, АС Пикина, ПА Голубинская… - Медицина …, 2024 - mes.elpub.ru
Аннотация В настоящее время клеточные технологии являются одним из
инструментов по восстановлению хрящевой ткани. Создание универсального …

PLURIPOTENCY AND PERSPECTIVES OF CELL TECHNOLOGIES

ED Erofeeva, VK Abdyev… - Vestnik Rossijskoj …, 2023 - journals.rcsi.science
Biology of pluripotency is a modern field of biological science, and at the same time a tool for
modeling human morphogenesis in vitro. Pluripotency is the property of cells to self-renew …